RE:Little SupportMy thinking at this point is that until Kincora can make the announcement on the ASX listing, nothing will happen with the share price. What is the point of releasing assay results, good, poor or indifferent, into this market? It looks to me that the seller is constantly lurking to ensure the share price does not climb above $.20
I had thought, hoped, that the share price would not drop below $.20, but here we are slightly under that price. Does it drop further? I doubt it, but if it does I don't think it would drop much lower and I think it will recover enough to not lose touch with $.20. ($.18 - $.20)
The 50 day moving average is right at $.25 which could still be of some consequence.
Frustrating for sure but unless you are prepared to sell at a loss there is not much an investor can do here but just sit back and wait for the announcement.
Now all of the above assumes that Kincora is prepared to go ahead with the ASX listing with an IPO price of $.20. If they are not prepared to list at that price then I'm not sure what happens from here. They would have to identify the seller and get them out of the way. With that pressure out of the way, the share price could head higher.
I still maintain that without the seller this stock would be priced closer to $.40!
J.M.O.
Chip